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Association of acquired autoimmune angioneurotic edema with other diseases
is increasing. However, the precise mechanism by which antibodies to
C1-esterase inhibitor (C1-INH) are produced, is not elucidated. We describe
a patient with IgA antibodies against C1-INH without other autoimmune




 infection, proven by




 infection can act as triggering factor for
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 is known to cause gastroduodenal
disorders. Emerging evidence implicates this bacteria in
the development of autoimmune disorders such
rheumatoid arthritis, Sjögrens syndrome, and idiopathic
thrombocytopenic purpura. Although several mechanisms
are elucidated, the precise process of initiating autoimmunity
is not known. We describe a patient having autoimmune





In March 2004, a 52-year-old Caucasian man was
admitted to our institution with severe abdominal pain
and swelling involving the lips and eyelids. As per his
wife’s description he had temporary loss of consciousness
and passed urine involuntarily. He did not have nausea,
vomiting, or other systemic complaints. He had a history of
myocardial infarction at the age of 37 years and was under
regular follow up and treatment. He had several episodes
of spontaneously resolving, mild swelling of eyelids, and
lips since the age of 43 years. During these years he also
had dyspepsia and aerophagia, for which he took
symptomatic treatment. Physical examination showed
angioedema of face, predominantly involving eyelids and
lips. Diffuse abdominal tenderness and guarding was
elicited. Other systemic examination appeared normal. His
ECG and cardiac markers on blood examination were
negative. To control his symptoms rapidly, methylpred-
nisolone 375 mg was given intravenously. Abdominal CT
scan showed gastric mucosal edema and mild ascites.
Consequently, emergency exploratory laparoscopy was
performed which revealed minimal ascites without any
other abdominal pathology. Ascitic fluid cytology and
culture were negative. Blood examination was normal;
however, C1-esterase inhibitor activity was not measured.
Favorable evolution of symptoms leads to his discharge the
next day. Two weeks later, the patient re-presented with
similar symptoms. Blood examination specifically for
acquired angioedema revealed a low C4 levels (< 0.01 g/L;
normal values: 0.10–0.41); decreased C1 esterase inhibitor
activity (< 12.5%; normal values: 70–130), and CH50
activity (< 12.5%; normal values: 75–100). The patient
was treated with 1500 U of C1-esterase inhibitor con-
centrate and fresh frozen plasma intravenously. Due to
the aggravation of his dyspeptic symptoms, a gastroscopy





, chronic duodenitis, and chronic gastritis
with metaplasia involving the gastric antrum and fundus.





using the complement fixation test by Institute Virion
which has a sensitivity and specificity 74.4% and 77.6%,




eradication therapy comprising amoxycillin (1 g twice
daily), clarithromycin (500 mg twice daily), and lansoprazole
(30 mg twice daily) for 10 days.
For confirmation of the diagnosis of C1-INH deficiency,
a sample was sent to Milan which showed IgA autoanti-
bodies against C1-INH, with a normal concentration of the
C1-INH protein. The patient was started on Danatrol
200 mg per day as prophylaxis. But he continued to have
episodes of angioneurotic edema, following which the
dose of Danatrol was increased to 200 mg three times per
day. The dose of Danatrol was tapered over time and
presently, our patient is doing well without further symptoms.
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Defective C1-INH function predisposes to episodes of
self-limited, increased vascular permeability (angioedema)
that is restricted to three specific sites, which include
subcutaneous space, the gut, and the upper airway [1].
Acquired form of C1-INH deficiency was first identified
and described by Caldwell et al. in 1972 and came to be
known as acquired angioneurotic edema (AAE) [2].
Several authors have contributed to the description of
AAE in the context of other disorders most commonly
lymphoproliferative diseases (also cryoglobulinemia,
adenocarcinoma, SLE, autoimmune hemolytic anemia,
planar xanthomatosis, myelofibrosis, ovarian teratoma,
recurrent panniculitis, and liver hydatidosis). Besides, this
syndrome is recognizable in otherwise healthy subjects [3].
Autoimmune C1-INH deficiency was observed in the
year 1986, in a patient without lymphoproliferation and
whose serum contained autoantibody to C1-INH. Charac-
teristic features of this syndrome included oligoclonal or
monoclonal autoantibodies; low serum levels of C1q, C4,
and C2; normal serum levels of C3; and normal or reduced
serum levels of C1-INH protein, which is functionally
inactive [4]. Therefore, two mechanisms of acquired defect
of C1-INH are autoantibodies against this protein and
an associated diseases causing increase catabolism [1].
Furthermore, it was observed that in autoimmune AAE,
the autoantibody does not prevent the cleavage of C1-INH
by the target proteases, but blocks its activity. The native
C1-INH is depleted and the cleaved inactive form accu-
mulates in plasma, resulting in higher levels of C1-INH
antigen than C1-INH function [2].
In a study comprising 13 patients with nonhereditary
angioedema, the relationship between presence of
autoantibodies to C1-INH to the cleaved form of C1-INH
and to paraproteins were evaluated. The authors suggested
that autoantibodies destabilize the C1-INH-protease complex
or enhance susceptibility of C1-INH to the cleavages by
proteases which do not form stable complexes. It was
demonstrated that circulating autoantibodies facilitate the
accumulation of cleaved C1-INH in plasma and the contact
system activation participates in this phenomenon [3].
Circulating autoantibodies were observed in all but one
patient having chronic lymphocytic leukemia. Consequently,
they mentioned the need to reconsider all patients so far
described having AAE secondary to another disease may
have autoantibodies induced AAE [3].
The etiology of AAE remains controversial and elusive.
The triggering factor for the production of autoantibodies




 infection acts as a triggering factor of attacks in
patients with hereditary angioedema [5]. Moreover,




infection with various skin disorder which were previously
considered as autoimmune disease [6,7].





implicated in various autoimmune diseases such rheumatoid
arthritis, Sjögrens syndrome, and idiopathic thrombocyto-




 infection generates autoimmune disorders
remains to be elucidated, the production of rheumatoid
factors (RF) seems to be a key event in initiating auto-
immunity. The authors demonstrated the active production
of various B1-cell-associated autoreactive antibodies such
as IgM-type RF, antisingle-stranded DNA (ssDNA) antibody,
and antiphosphatidyl choline antibody as well as IgG3 in





 urease in vitro. B1 cells are thought to be
the primary source of natural IgM antibodies, which are
usually polyreactive and autoreactive against bacterial
polysaccharide, lipids, and proteins as well as autoantigens
such as ssDNA and IgG-like RFs. These self-antigens
reactive antibodies may bind to their own components
initiate an inflammatory response and contribute to the
pathogenesis of various autoimmune disorders. Hence,
normally the eradication of the organism should reduce
the incidence of the disease [8].
Interestingly, besides the presence of antibodies against
C1-INH, no autoimmune abnormalities namely antinuclear
antibodies, RF, cryoglobulins, or antithyroid antibodies




 could be responsible for formation of anti-C1-INH
antibodies and worsening angioedema. A case report from
Germany on AAE (in the year 1999) suggested that exces-





 is a potential cause of C1-INH deficiency





cause of AAE was never considered before. Additionally,
we postulate that autoantibodies directed against C1-INH
could play a role in the attacks observed in the patients
with the genetic form of the disease and with residual levels
of protein and also in some cases of idiopathic urticaria










evolvement of autoimmune diseases. Considering the
higher incidence of infection with this bacteria and rarity
of autoimmune diseases, genetic susceptibility should be
considered as an important triggering factor.
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